Trending...
- New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks
- Koplon Dentistry Elevates Implant Expertise with Advanced CE Course
- 'Wild Hermit Wellness' Has Achieved Bestseller Status in Just 2 Months Since Launch Of Organic Skincare Line
BELLEFONTE, Pa. - PennZone -- Actuated Medical, Inc. is pleased to announce that Roger B. Bagwell, Ph.D. is now the Actuated Medical Director, Neural Device Operations. This transition reflects the company's continued expansion in the neural device sector and Dr. Bagwell's pivotal role in advancing Actuated's cutting-edge technologies.
As Director, Neural Device Operations, Dr. Bagwell will oversee the development, optimization, and strategic direction of Actuated's neural-focused device portfolio, Actuated Neuroscience, ensuring performance excellence from concept to commercialization. He will lead engagement with brain researchers and brain computer interface (BCI) companies that are focused on improving outcomes for patients dealing with neurological conditions.
"Our team has made significant strides in helping the neural device researcher achieve better data to improve their understanding of the brain. With Roger at the helm of our neural device operations, we are confident that we will continue delivering groundbreaking solutions to enable clinical researchers to improve patient outcomes." said Maureen L. Mulvihill, Ph.D., President and CEO of Actuated Medical.
More on The PennZone
"I am excited to take this step and transition my position to Director, Neural Device Operations. Actuated Neuroscience has an immense amount of neural technology ideas, and I look forward to leading our talented team in developing advanced solutions that enhance patient care and expand the possibilities of neural device applications." said Roger B. Bagwell, Ph.D.
Actuated Medical is committed to pushing the boundaries of medical technology through innovation and collaboration. This transition underscores the company's dedication to developing advanced solutions that extend the longevity and performance of penetrating neural implants and other neuro-focused medical devices.
About Actuated Medical, Inc.
Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 43 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified ISO 13485 and a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com
More on The PennZone
###
For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.
Additional information can be found by visiting:
ActuatedMedical.com
GripTract.com
ActuatedNeuroscience.com
TubeClear.com
As Director, Neural Device Operations, Dr. Bagwell will oversee the development, optimization, and strategic direction of Actuated's neural-focused device portfolio, Actuated Neuroscience, ensuring performance excellence from concept to commercialization. He will lead engagement with brain researchers and brain computer interface (BCI) companies that are focused on improving outcomes for patients dealing with neurological conditions.
"Our team has made significant strides in helping the neural device researcher achieve better data to improve their understanding of the brain. With Roger at the helm of our neural device operations, we are confident that we will continue delivering groundbreaking solutions to enable clinical researchers to improve patient outcomes." said Maureen L. Mulvihill, Ph.D., President and CEO of Actuated Medical.
More on The PennZone
- A Girl's Gotta Spa!® Launches Synergy Body Wash to Elevate the Everyday Shower
- Political Division and Safety Concerns Drive Record Number of Americans to Seek "Golden Visas," La Vida Survey Finds
- The Citizens Commission on Human Rights of Florida Celebrates Volunteers and Community Partners at the 9th Annual Humanitarian Awards Banquet
- J French's #1 Album "I Don't Believe in Bad Days" Enters the Grammy Conversation
- Words of Veterans & Veterans Growing America Collaboration
"I am excited to take this step and transition my position to Director, Neural Device Operations. Actuated Neuroscience has an immense amount of neural technology ideas, and I look forward to leading our talented team in developing advanced solutions that enhance patient care and expand the possibilities of neural device applications." said Roger B. Bagwell, Ph.D.
Actuated Medical is committed to pushing the boundaries of medical technology through innovation and collaboration. This transition underscores the company's dedication to developing advanced solutions that extend the longevity and performance of penetrating neural implants and other neuro-focused medical devices.
About Actuated Medical, Inc.
Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 43 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified ISO 13485 and a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com
More on The PennZone
- Mature Athlete - Want Elite, Web-Based Nutrition and Training Coaching?
- Engaged at Any Age: 73-Year-Old Client Finds True Love Through Elite Asian Matchmaker
- Launch of Professional Private Autopsy Services to Support Families, Professionals, and Researchers
- He Started a New Career at 77; Maybe Not His Last
- "The Art of Philanthropy" — A Year-Long Campaign Supporting the USO and Military Veterans
###
For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.
Additional information can be found by visiting:
ActuatedMedical.com
GripTract.com
ActuatedNeuroscience.com
TubeClear.com
Source: Actuated Medical, Inc.
0 Comments
Latest on The PennZone
- Delta Capital Group Expands Business Funding Terms Up to 24 Months
- Hip-HopVibe.com Launches HHV Media Network in Partnership with The Publisher Desk
- Patient Weather introduces POI, the Peterlin OxyWeather Index
- CCHR: Misinformation Clouds Debate on Psychiatric Drug Toxicology Transparency
- Hilton Head Realtor becomes Certified Senior Professional
- Bitcoin at $115K: AZETHIO Launches Exchange Targeting Institutional Compliance Requirements
- Tech gains propel Dow Jones past 47,000 as markets reach record highs amid trade tensions
- Edu Alliance Group Launches the Center for College Partnerships and Alliances
- Three Cord True Wealth Management Unveils New Website for Better Client Communication
- Generation Own: Why Young Americans Are Skipping Corporate Careers to Buy Million-Dollar Businesses
- Dongsheng's Titanium Recycling Business Enters Aerospace Sector by 2025
- Crowdfunding Campaign Tips Off for 'NAWFSIDE' Short Film Highlighting Pressure in Youth Sports
- Icarus IFE Systems Launches the Icarus One Portable Inflight Entertainment System — The World's Most Advanced Offline AI-Driven IFE Platform
- Local Boyertown Auto Shop Announces Expansion Due to Overwhelming Customer Demand
- AEI Stands Firmly with Pakistani Aircraft Engineers facing retaliation for reporting safety concerns
- Literary fiction novel- 'Skylark' wins Bronze Medal
- Kaltra unveils reversible microchannel coils – engineered for modern heat pumps
- Phinge Announces Proposal to Combat Billions in Government Waste, Fraud, and Abuse with Proactive, Hardware-Verified Netverse App-Less Platform
- Taboo: The Lost Codes of Men — A Bold New Book Confronting the Crisis of Modern Manhood
- Phinge's Netverse to Redefine Clinical Trial Safety and Data Integrity with Netverse Patented, Hardware-Verified Platform
